Premier Alternatives

Stylus Medicine

Drug Discovery · Cambridge, MA · Founded 2022 · Privately Held (backing)

Developer of in vivo genetic medicines designed to enable precise insertion of therapeutic genetic material within the human genome. Stylus Medicine is based in Cambridge, MA and was founded in 2022. It was valued at $114 million at its early-stage round in May 2025, the last priced event on record. It has raised $93 million across 1 recorded round; the latest was an $85 million Series A in May 2025.

PMV mark · valuation
$114.0M
Oct 2026
Priced at
its early-stage round
May 2025
Total raised
$93.0M
Last round
Early Stage VC (Series A)
May 2025

Stylus Medicine key facts

as of Oct 2026
  • Developer of in vivo genetic medicines designed to enable precise insertion of therapeutic genetic material within the human genome.
  • Stylus Medicine is valued at approximately $114.0M as of Oct 2026, set at its early-stage round, May 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $93.0M across 1 recorded rounds; the latest was Early Stage VC (Series A) ($85.0M) in May 2025.
  • Notable investors include Khosla Ventures, RA Capital Management, University of California, Johnson & Johnson JJDC, Brainstorm Ventures — 12 tracked in total.
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$114.0M

Valued at $114.0M at its early-stage round, May 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Stylus Medicine with a free account
  • ·The complete investor list: 12 names
  • ·Watch Stylus Medicine: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Stylus Medicine funding rounds

1 rounds
May 2025Early Stage VC (Series A)$85.0M▮
Full funding history →

Stylus Medicine valuation

Stylus Medicine was valued at $114 million at its early-stage round in May 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Stylus Medicine raised?

Stylus Medicine has raised $93 million across 1 recorded round since 2025. The largest was an $85 million Series A in May 2025.

Stylus Medicine investors

12 investors are on record for Stylus Medicine, including Khosla Ventures, RA Capital Management, University of California and Johnson & Johnson JJDC. By type, the record holds 4 venture capital firms and 1 asset manager. The Series A in May 2025 drew 9 investors.

Comparable companies

Comparable drug discovery names by valuation on PrivateMarketView: Arsenal Medical ($124 million), Nocion Therapeutics ($112 million) and Kernalbio ($111 million).

About Stylus Medicine

Developer of in vivo genetic medicines designed to enable precise insertion of therapeutic genetic material within the human genome. The company offers engineered recombinase technology, targeted lipid nanoparticle delivery, and gene integration capabilities for complex therapeutic payloads, enabling healthcare and biotechnology researchers to develop treatments for oncology, autoimmune, and genetic diseases.

Industry
Drug Discovery
Sector
Healthcare
HQ
Cambridge, MA, United States
Founded
2022
Employees
40
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.